Literature DB >> 20385287

Unexplained cervical lymphadenopathy in children: predictive factors for malignancy.

Jingfu Wang1, Guanghua Pei, Jie Yan, Qiang Zhao, Zhanglin Li, Yanna Cao, Jie Li, Guangchao Zhang, Hongjun Chen, Xishan Hao.   

Abstract

PURPOSE: The purpose of this study was to determine clinical factors that are able to predict the likelihood of malignancy of unexplained cervical lymphadenopathy in children.
METHODS: The data of 175 cases with unexplained cervical lymphadenopathy, including sex, age, fever, number of involved regions, and location and size of the largest node, were collected. Receiver operating characteristic analysis was performed to find out the optimal parameter for size of the largest node. Logistic regression was applied to determine independent predictors for malignancy.
RESULTS: On the basis of receiver operating characteristic analysis, the ratio of maximal width to maximal length (ratio) was confirmed as the optimal parameter of size for malignancy prediction, and its threshold, which maximized sensitivity and specificity, was 0.5. Multivariate binary logistic regression model indicated that number of involved regions (odds ratio [OR], 5.169; 95% confidence interval [CI], 1.291-20.691; P = .020), location of the largest node (OR, 12.423; 95% CI, 3.657-42.205; P = .000), and ratio (OR, 52.080; 95% CI, 16.089-168.588; P = .000) were significant independent predictors of malignancy.
CONCLUSIONS: Higher ratio (>0.5), multiple cervical regions of adenopathy (> or =2), and region II or III location of the largest node are associated with malignancy. These data should be helpful to supplement clinical judgment in determining which enlarged cervical nodes harbor cancer. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20385287     DOI: 10.1016/j.jpedsurg.2009.08.018

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  1 in total

1.  Predictive factors for malignancy in patients with persistent cervical lymphadenopathy.

Authors:  Fatih Celenk; Secaattin Gulsen; Elif Baysal; Ismail Aytac; Seval Kul; Muzaffer Kanlikama
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-07-18       Impact factor: 2.503

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.